Investors Sell Johnson & Johnson (NYSE:JNJ) on Strength (NYSE:JNJ)
Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Wednesday. $98.84 million flowed into the stock on the tick-up and $286.20 million flowed out of the stock on the tick-down, for a money net flow of $187.36 million out of the stock. Of all companies tracked, Johnson & Johnson had the highest net out-flow for the day. Johnson & Johnson traded up $0.96 for the day and closed at $133.23
Several equities analysts have recently issued reports on the stock. UBS AG restated a “buy” rating and set a $136.00 price objective on shares of Johnson & Johnson in a report on Monday, May 15th. Vetr upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $132.33 target price on the stock in a research report on Thursday, May 18th. Stifel Nicolaus reiterated a “hold” rating and issued a $128.00 target price (up previously from $124.00) on shares of Johnson & Johnson in a research report on Thursday, May 18th. BidaskClub upgraded Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 17th. Finally, Wells Fargo & Company reiterated a “market perform” rating and issued a $135.00 target price (up previously from $132.00) on shares of Johnson & Johnson in a research report on Thursday, July 6th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and eleven have assigned a buy rating to the stock. Johnson & Johnson presently has an average rating of “Hold” and an average price target of $133.72.
The company has a market cap of $358.90 billion, a price-to-earnings ratio of 22.54 and a beta of 0.78. The company has a 50 day moving average of $133.35 and a 200-day moving average of $125.64.
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.04. Johnson & Johnson had a return on equity of 26.76% and a net margin of 22.52%. The company had revenue of $18.84 billion for the quarter, compared to analysts’ expectations of $18.94 billion. During the same period last year, the firm earned $1.74 EPS. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. Equities research analysts forecast that Johnson & Johnson will post $7.18 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Tuesday, August 29th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.52%. The ex-dividend date is Friday, August 25th. Johnson & Johnson’s dividend payout ratio (DPR) is presently 56.76%.
In other news, VP Dominic J. Caruso sold 82,591 shares of the firm’s stock in a transaction on Thursday, July 20th. The stock was sold at an average price of $136.72, for a total transaction of $11,291,841.52. Following the completion of the sale, the vice president now directly owns 226,693 shares of the company’s stock, valued at approximately $30,993,466.96. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Paulus Stoffels sold 102,692 shares of the firm’s stock in a transaction on Monday, July 24th. The stock was sold at an average price of $133.14, for a total value of $13,672,412.88. Following the sale, the vice president now directly owns 230,342 shares of the company’s stock, valued at $30,667,733.88. The disclosure for this sale can be found here. 0.19% of the stock is currently owned by company insiders.
Several large investors have recently added to or reduced their stakes in the company. State Street Corp raised its stake in Johnson & Johnson by 4.3% in the first quarter. State Street Corp now owns 160,223,321 shares of the company’s stock valued at $19,955,806,000 after buying an additional 6,656,371 shares in the last quarter. Norges Bank bought a new stake in Johnson & Johnson during the fourth quarter valued at $3,220,322,000. Schwab Charles Investment Management Inc. raised its stake in Johnson & Johnson by 4.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 11,623,639 shares of the company’s stock valued at $1,537,692,000 after buying an additional 473,300 shares in the last quarter. Fisher Asset Management LLC raised its stake in Johnson & Johnson by 3.7% in the second quarter. Fisher Asset Management LLC now owns 11,499,415 shares of the company’s stock valued at $1,521,258,000 after buying an additional 405,517 shares in the last quarter. Finally, Swiss National Bank raised its stake in Johnson & Johnson by 2.7% in the second quarter. Swiss National Bank now owns 10,738,464 shares of the company’s stock valued at $1,420,591,000 after buying an additional 277,800 shares in the last quarter. 66.06% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Investors Sell Johnson & Johnson (NYSE:JNJ) on Strength (NYSE:JNJ)” was originally published by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.watchlistnews.com/investors-sell-johnson-johnson-nysejnj-on-strength-nysejnj/1466684.html.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.